Metin Nafi Gürcan

Name: dblp XML data dump
Creator: Schloss Dagstuhl - Leibniz Center for Informatics
Published: 1993
License: https://creativecommons.org/publicdomain/zero/1.0/
Keywords: dblp, XML, computer science, scholarly publications, metadata

◀ ▶ joint publications with Vidya Arole

> Home > Persons > Metin Nafi Gürcan

Publications

2019
[c69]
- view
  authority control:
- export record
  dblp key:
  - conf/midp/NiaziTSTHAPG19
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/midp/NiaziTSTHAPG19
Muhammad Khalid Khan Niazi, Thomas E. Tavolara, Çaglar Senaras, Gary Tozbikian, Douglas J. Hartman, Vidya Arole, Liron Pantanowitz, Metin N. Gurcan:
Generalization of tumor identification algorithms. Medical Imaging: Digital Pathology 2019: 109560Z
[c68]
- view
  authority control:
- export record
  dblp key:
  - conf/midp/SenarasNACSSLHL19
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/midp/SenarasNACSSLHL19
Çaglar Senaras, M. Khalid Khan Niazi, Vidya Arole, Weijie Chen, Berkman Sahiner, Arwa Shana'ah, Abner Louissaint, Robert Paul Hasserjian, Gerard Lozanski, Metin Nafi Gürcan:
Segmentation of follicles from CD8-stained slides of follicular lymphoma using deep learning. Medical Imaging: Digital Pathology 2019: 109560R
2018
[c64]
- view
  authority control:
- export record
  dblp key:
  - conf/midp/NiaziTAPLG18
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/midp/NiaziTAPLG18
M. Khalid Khan Niazi, Thomas E. Tavolara, Vidya Arole, Anil V. Parwani, Cheryl Lee, Metin N. Gurcan:
Automated T1 bladder risk stratification based on depth of lamina propria invasion from H and E tissue biopsies: a deep learning approach. Medical Imaging: Digital Pathology 2018: 105810H

a service of

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.